AbbVie Inc. (NYSE: ABBV)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 246.66 (-10.95 / -4.25%) | 250.88 (-6.53 / -2.54%) | 251.94 (+1.06 / +0.42%) |
| 31-Jul 09:19 | 31-Jul 16:00 | 31-Jul 18:59 |
Sector: Healthcare || Industry: Drug Manufacturers - General
| Previous Close | 257.41 | Year Low | 189.79 |
| Open | 250.46 | Year High | 267.47 |
| Day Low | 247.00 | Price Avg 50 | 237.33 |
| Day High | 255.11 | Price Avg 200 | 224.59 |
| Volume | 4.88 M | Market Cap | 443.24 B |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| ABBV | -2.54 | -2.96 | -0.30 | 18.72 | 12.49 | 32.72 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/31/2026 | BMO | ABBV | AbbVie | Q2 2026 | EPS | 3.70 | 2.97 | ||||
| 07/31/2026 | BMO | ABBV | AbbVie | Q2 2026 | REV | 16.75 B | 0.00 | 15.42 B | 0.00 | ||
| 04/29/2026 | BMO | ABBV | AbbVie | Q1 2026 | EPS | 2.59 | 2.65 | 2.32 | 2.46 | 7.70 | |
| 04/29/2026 | BMO | ABBV | AbbVie | Q1 2026 | REV | 14.72 B | 15.00 B | 1.90 | 13.34 B | 12.43 | |
| 02/04/2026 | BMO | ABBV | AbbVie | Q4 2025 | EPS | 2.65 | 2.71 | 2.26 | 2.16 | 25.50 | |
| 02/04/2026 | BMO | ABBV | AbbVie | Q4 2025 | REV | 16.42 B | 16.62 B | 1.20 | 15.10 B | 10.05 | |
| 10/31/2025 | BMO | ABBV | AbbVie | Q3 2025 | EPS | 1.79 | 1.86 | 3.91 | 3.00 | -38.00 | |
| 10/31/2025 | BMO | ABBV | AbbVie | Q3 2025 | REV | 15.59 B | 15.78 B | 1.19 | 14.46 B | 9.10 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/06/2026 | 04:12 PM | ABBV | AbbVie | Q2 2026 | EPS | $3.77 | $3.57 ~ $3.61 | 0.00 | 3.59 | -4.77 | 20.9 | 47,684 | |||||||||||
| 07/06/2026 | 04:12 PM | ABBV | AbbVie | FY 2026 | EPS | $14.24 | $13.91 ~ $14.11 | $14.08 ~ $14.28 | 0.00 | 14.01 | 14.18 | -1.62 | -1.20 | 47,685 | |||||||||
| 04/29/2026 | 07:47 AM | ABBV | AbbVie | FY 2026 | EPS | $14.12 | $14.08 ~ $14.28 | $14.37 ~ $14.57 | 0.00 | 14.18 | 14.47 | 0.42 | -2.00 | 46,140 | |||||||||
| 04/03/2026 | 04:06 PM | ABBV | AbbVie | FY 2026 | EPS | $14.24 | $13.96 ~ $14.16 | $14.37 ~ $14.57 | 0.00 | 14.06 | 14.47 | -1.26 | -2.83 | 45,634 | |||||||||
| 04/03/2026 | 04:06 PM | ABBV | AbbVie | Q1 2026 | EPS | $3.10 | $2.56 ~ $2.60 | $2.97 ~ $3.01 | 0.00 | 2.58 | 2.99 | -16.77 | 4.9 | -13.71 | 45,635 | ||||||||
| 02/04/2026 | 09:00 AM | ABBV | AbbVie | Q1 2026 | EPS | $3.10 | $2.97 ~ $3.01 | 0.00 | 2.99 | -3.55 | 21.5 | 42,787 | |||||||||||
| 02/04/2026 | 09:00 AM | ABBV | AbbVie | Q1 2026 | REV | $15.00 B | $14.70 B | 0.00 | 14,700.00 | -2.01 | 10.2 | 42,787 | |||||||||||
| 02/04/2026 | 09:00 AM | ABBV | AbbVie | FY 2026 | EPS | $14.24 | $14.37 ~ $14.57 | 0.00 | 14.47 | 1.62 | 42,788 | ||||||||||||
| 02/04/2026 | 09:00 AM | ABBV | AbbVie | FY 2026 | REV | $66.96 B | $67.00 B | 0.00 | 67,000.00 | 0.06 | 42,788 | ||||||||||||
| 01/07/2026 | 08:00 AM | ABBV | AbbVie | Q4 2025 | EPS | $2.65 | $3.32 ~ $3.36 | $3.32 ~ $3.36 | 0.00 | 3.34 | 3.34 | 26.04 | 54.6 | 42,789 | |||||||||
| 01/07/2026 | 08:00 AM | ABBV | AbbVie | FY 2025 | EPS | $9.94 | $10.61 ~ $10.65 | $10.61 ~ $10.65 | 0.00 | 10.63 | 10.63 | 6.94 | 42,790 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 06/23/2026 | ABBV | Canaccord Genuity | Buy | Buy | Maintain |
| 06/23/2026 | ABBV | Piper Sandler | Overweight | Overweight | Maintain |
| 05/15/2026 | ABBV | Evercore ISI Group | Outperform | Outperform | Maintain |
| 05/14/2026 | ABBV | Piper Sandler | Overweight | Overweight | Maintain |
| 05/04/2026 | ABBV | Evercore ISI Group | Outperform | Outperform | Maintain |
| 05/01/2026 | ABBV | Guggenheim | Buy | Buy | Maintain |
| 04/30/2026 | ABBV | Morgan Stanley | Overweight | Overweight | Maintain |
| 04/30/2026 | ABBV | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 04/30/2026 | ABBV | Canaccord Genuity | Buy | Buy | Maintain |
| 04/23/2026 | ABBV | Piper Sandler | Overweight | Overweight | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|---|---|---|---|---|---|---|---|---|
| 06/18/2026 | ABBV | AbbVie | Quarterly | 1.73 | 0.03 | 07/15/2026 | 07/15/2026 | 08/14/2026 | Increased |
| 02/19/2026 | ABBV | AbbVie | Quarterly | 1.73 | 0.03 | 04/15/2026 | 04/15/2026 | 05/15/2026 | Increased |
| 10/31/2025 | ABBV | AbbVie | Quarterly | 1.64 | 0.03 | 01/16/2026 | 01/16/2026 | 02/17/2026 | Increased |
| 09/05/2025 | ABBV | AbbVie | Quarterly | 1.64 | 0.03 | 10/15/2025 | 10/15/2025 | 11/14/2025 | Increased |
Sign-Up to see the full list of CATALYSTS in the Calendars
